Search

Author/Creator Reding, Mark T.

1. A laparoscopic approach to address massive splenomegaly, symptomatic cholelithiasis, and a planned postoperative pregnancy: A case report. Issue 1 (23rd January 2023)

Authors:
Bishop, Alexandra A.; Krohn, Eric; Vakayil, Victor R.; Pribyl, Kyle; Reding, Mark T.; Tignanelli, Christopher; Harmon, James V.
Journal:
Clinical case reports
Issue:
Volume 11:Issue 1(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. BAY 94‐9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results. Issue 6 (17th October 2019)

Authors:
Lalezari, Shadan; Reding, Mark T.; Pabinger, Ingrid; Holme, Pal Andre; Negrier, Claude; Chalasani, Pavani; Shin, Ho‐Jin; Wang, Maria; Tseneklidou‐Stoeter, Despina; Maas Enriquez, Monika
Journal:
Haemophilia
Issue:
Volume 25:Issue 6(2019)
Page Start:
1011
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Confirmed long‐term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A: final results of the PROTECT VIII extension study. Issue 3 (5th April 2021)

Authors:
Reding, Mark T.; Pabinger, Ingrid; Holme, Pal Andre; Poulsen, Lone; Negrier, Claude; Chalasani, Pavani; Maas Enriquez, Monika; Wang, Maria; Meijer, Karina; Mancuso, Maria Elisa; Lalezari, Shadan
Journal:
Haemophilia
Issue:
Volume 27:Issue 3(2021)
Page Start:
e347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors. Issue 6 (6th October 2021)

Authors:
Escobar, Miguel; Luck, James; Averianov, Yevhenii; Ducore, Jonathan; Fernández, Maria Fernanda López; Giermasz, Adam; Hart, Daniel P.; Journeycake, Janna; Kessler, Craig; Leissinger, Cindy; Mahlangu, Johnny; Martinez, Laura Villarreal; Miesbach, Wolfgang; Mitha, Ismail Haroon; Quon, Doris; Reding...
Journal:
Haemophilia
Issue:
Volume 27:Issue 6(2021)
Page Start:
911
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during surgery in patients with severe hemophilia A: Results of the PROTECT VIII clinical trial. Issue 183 (November 2019)

Authors:
Santagostino, Elena; Lalezari, Shadan; Reding, Mark T.; Ducore, Jonathan; Ng, Heng Joo; Poulsen, Lone H.; Michaels, Lisa A.; Linardi, Camila C.G.
Journal:
Thrombosis research
Issue:
Issue 183(2019)
Page Start:
13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Safety and efficacy of BAY 94–9027, an extended‐half‐life factor VIII, during minor surgical procedures in patients with severe haemophilia A. Issue 4 (3rd May 2021)

Authors:
Santagostino, Elena; Lalezari, Shadan; Reding, Mark T.; Ducore, Jonathan; Ng, Heng Joo; Poulsen, Lone H.; Michaels, Lisa A.; Linardi, Camila
Journal:
Haemophilia
Issue:
Volume 27:Issue 4(2021)
Page Start:
e559
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗